Literature DB >> 15588782

Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

Yasutaka Mamiya1, Hidenori Kanazawa, Yuu Kimura, Yoshiyuki Narahara, Yuuichirou Yamate, Katsuhisa Nakatsuka, Choitsu Sakamoto.   

Abstract

The aim of this prospective study was to investigate the incidence, clinical features and the short- and long-term clinical course of hepatic encephalopathy (HE) after transjugular intrahepatic portosystemic shunt (TIPS) in Japanese patients. Eighty-seven consecutive patients with liver cirrhosis presenting with complications of portal hypertension underwent TIPS. The mean follow-up period after TIPS was 866 days. During the follow-up, HE occurred in 52% of patients throughout the follow-up period. The cumulative incidence of post-TIPS HE was 50.5+/-5.6% at 1 year (mean+/-S.D.). Most cases (89%) occurring within 7 days were easily controlled by the conventional therapy. Only two patients developed severe chronic HE, which was treated by reducing the shunt diameter. Older age, indication for TIPS (ascites) and higher retention rate of indocyanine green at 15min were identified as risk factors for post-TIPS HE. During long-term follow-up, the incident of post-TIPS HE decreased among survivals. The cumulative survival rate was similar in patients with or without post-TIPS HE. Our results indicate that post-TIPS HE are a frequent complication, particularly in the early months after TIPS. However, it can be easily managed in the majority of patients. The development of post-TIPS HE is not associated with poor prognosis in TIPS patients.

Entities:  

Year:  2004        PMID: 15588782     DOI: 10.1016/j.hepres.2004.09.003

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  6 in total

Review 1.  [Portosystemic shunt surgery between TIPS and liver transplantation].

Authors:  G Puhl; S Gül; P Neuhaus
Journal:  Chirurg       Date:  2011-10       Impact factor: 0.955

2.  Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical Outcomes.

Authors:  Leigh C Casadaban; Ahmad Parvinian; Jeet Minocha; Janesh Lakhoo; Christopher W Grant; Charles E Ray; M Grace Knuttinen; James T Bui; Ron C Gaba
Journal:  Dig Dis Sci       Date:  2014-10-15       Impact factor: 3.199

3.  A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt.

Authors:  Yinglong Li; Xiaofeng He; Huajin Pang
Journal:  Turk J Gastroenterol       Date:  2019-08       Impact factor: 1.852

4.  Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial.

Authors:  Yoshiyuki Narahara; Hidenori Kanazawa; Takeshi Fukuda; Yoko Matsushita; Hirotomo Harimoto; Hideko Kidokoro; Tamaki Katakura; Masanori Atsukawa; Yasuhiko Taki; Yuu Kimura; Katsuhisa Nakatsuka; Choitsu Sakamoto
Journal:  J Gastroenterol       Date:  2010-07-15       Impact factor: 7.527

Review 5.  Update on the management of gastrointestinal varices.

Authors:  Umesha Boregowda; Chandraprakash Umapathy; Nasir Halim; Madhav Desai; Arpitha Nanjappa; Subramanyeswara Arekapudi; Thimmaiah Theethira; Helen Wong; Marina Roytman; Shreyas Saligram
Journal:  World J Gastrointest Pharmacol Ther       Date:  2019-01-21

6.  Hyponatremia: A Risk Factor for Early Overt Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.

Authors:  Jonathan Merola; Noami Chaudhary; Meng Qian; Alexander Jow; Katherine Barboza; Hearns Charles; Lewis Teperman; Samuel Sigal
Journal:  J Clin Med       Date:  2014-04-04       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.